Skip to Main Content

Author Details

Daniela Mihic-Probst
University Hospital Zurich
2001
72
28
PMIDPaper TitleJournal TitlePublished Year
36630138Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.JAMA Netw Open2023
36630138Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.JAMA Netw Open2023
37098294Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis.Eur J Cancer2023
37098294Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis.Eur J Cancer2023
34324996Intraneural fibrosis and loss of microvascular architecture - Key findings investigating failed human nerve allografts.Ann Anat2022
36028468Adult xanthogranuloma with LMNA-NTRK1 gene fusion - a possible driver of proliferation.J Dtsch Dermatol Ges2022
36162033Adultes Xanthogranulom mit LMNA-NTRK1-Genfusion - ein möglicher Proliferationsfaktor.J Dtsch Dermatol Ges2022
36160498Rare Choristoma of the Tarsal Conjunctiva: Critical Inspection Prevents Unnecessary Mutilation.Case Rep Ophthalmol2022
36142656Hypoxia and Ezrin Expression in Primary Melanoma Have High Prognostic Relevance.Int J Mol Sci2022
35805065Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. <i>Cancers</i> 2021, <i>13</i>, 3830.Cancers (Basel)2022
34324996Intraneural fibrosis and loss of microvascular architecture - Key findings investigating failed human nerve allografts.Ann Anat2022
35805065Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. <i>Cancers</i> 2021, <i>13</i>, 3830.Cancers (Basel)2022
36142656Hypoxia and Ezrin Expression in Primary Melanoma Have High Prognostic Relevance.Int J Mol Sci2022
36028468Adult xanthogranuloma with LMNA-NTRK1 gene fusion - a possible driver of proliferation.J Dtsch Dermatol Ges2022
36162033Adultes Xanthogranulom mit LMNA-NTRK1-Genfusion - ein möglicher Proliferationsfaktor.J Dtsch Dermatol Ges2022
36160498Rare Choristoma of the Tarsal Conjunctiva: Critical Inspection Prevents Unnecessary Mutilation.Case Rep Ophthalmol2022
33472206Ocular Pathology and Occasionally Detectable Intraocular Severe Acute Respiratory Syndrome Coronavirus-2 RNA in Five Fatal Coronavirus Disease-19 Cases.Ophthalmic Res2021
34063555Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients.Diagnostics (Basel)2021
33472206Ocular Pathology and Occasionally Detectable Intraocular Severe Acute Respiratory Syndrome Coronavirus-2 RNA in Five Fatal Coronavirus Disease-19 Cases.Ophthalmic Res2021
33768288Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [<sup>18</sup>F]FDG PET/CT.Eur Radiol2021
34757982Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms.Am J Surg Pathol2021
34359730Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.Cancers (Basel)2021
33768288Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [<sup>18</sup>F]FDG PET/CT.Eur Radiol2021
34757982Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms.Am J Surg Pathol2021
34063555Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients.Diagnostics (Basel)2021
34359730Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.Cancers (Basel)2021
32238882Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.Oncogene2020
32014933Progressive Disease in Sentinel-negative Melanoma Patients: Biological Differences and Importance of Sentinel Lymph Node Biopsy.Anticancer Res2020
32238882Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.Oncogene2020
32962812The role of macrophages type 2 and T-regs in immune checkpoint inhibitor related adverse events.Immunobiology2020
32619863Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications.Cancer Treat Rev2020
32014933Progressive Disease in Sentinel-negative Melanoma Patients: Biological Differences and Importance of Sentinel Lymph Node Biopsy.Anticancer Res2020
32962812The role of macrophages type 2 and T-regs in immune checkpoint inhibitor related adverse events.Immunobiology2020
32619863Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications.Cancer Treat Rev2020
30927294Eight autopsy cases of melanoma brain metastases showing angiotropism and pericytic mimicry. Implications for extravascular migratory metastasis.J Cutan Pathol2019
30927294Eight autopsy cases of melanoma brain metastases showing angiotropism and pericytic mimicry. Implications for extravascular migratory metastasis.J Cutan Pathol2019
31428638Erratum to "Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma".Biomed Res Int2019
30723298The value of axillary skin electron microscopic analysis in the diagnosis of lysosomal storage disorders.Mod Pathol2019
31428638Erratum to "Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma".Biomed Res Int2019
30723298The value of axillary skin electron microscopic analysis in the diagnosis of lysosomal storage disorders.Mod Pathol2019
29785541New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiation.Virchows Arch2018
29491397Single cell polarity in liquid phase facilitates tumour metastasis.Nat Commun2018
29785541New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiation.Virchows Arch2018
29491397Single cell polarity in liquid phase facilitates tumour metastasis.Nat Commun2018
27871762Clinical and Histopathologic Ocular Findings in Disseminated Mycobacterium chimaera Infection after Cardiothoracic Surgery.Ophthalmology2017
28559410Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma.Oncologist2017
27871762Clinical and Histopathologic Ocular Findings in Disseminated Mycobacterium chimaera Infection after Cardiothoracic Surgery.Ophthalmology2017
28559410Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma.Oncologist2017
27048955Imaging of Angiotropism/Vascular Co-Option in a Murine Model of Brain Melanoma: Implications for Melanoma Progression along Extravascular Pathways.Sci Rep2016
27048955Imaging of Angiotropism/Vascular Co-Option in a Murine Model of Brain Melanoma: Implications for Melanoma Progression along Extravascular Pathways.Sci Rep2016
  • 1 - 50 of 144

Recommended Authors

Thomas Jefferson University
Career Start Year 2011
Number of shared co-authors 4
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 2009
Number of shared co-authors 7
University of Colorado Anschutz Medical Campus
Career Start Year 2008
Number of shared co-authors 4
Canisius Wilhelmina Hospital
Career Start Year 2006
Number of shared co-authors 0
Sestre milosrdnice University Hospital Centre
Career Start Year 2005
Number of shared co-authors 0
Westmead Hospital
Career Start Year 2004
Number of shared co-authors 0
Tufts Medical Center
Career Start Year 2004
Number of shared co-authors 0
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 2
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 5
Uppsala University
Career Start Year 2002
Number of shared co-authors 0
1Rijnstate Hospital
Career Start Year 2001
Number of shared co-authors 0
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Weizmann Institute of Science
Career Start Year 1998
Number of shared co-authors 9
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 8
UPMC Hillman Cancer Center
Career Start Year 1997
Number of shared co-authors 3
Thomas Jefferson University
Career Start Year 1996
Number of shared co-authors 7
Mayo Clinic Hospital
Career Start Year 1994
Number of shared co-authors 2
University of Colorado Anschutz Medical Campus
Career Start Year 1990
Number of shared co-authors 4
University of Virginia
Career Start Year 1987
Number of shared co-authors 2
University of Melbourne
Career Start Year 1986
Number of shared co-authors 7
The University of Texas MD Anderson Cancer Center
Career Start Year 1985
Number of shared co-authors 6
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 9
Medical University of Vienna
Career Start Year 1983
Number of shared co-authors 0
QIMR Berghofer Medical Research Institute
Career Start Year 1982
Number of shared co-authors 6
Saint John's Cancer Institute at Saint John's Health Center
Career Start Year 1982
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 2
UPMC Hillman Cancer Center
Career Start Year 1974
Number of shared co-authors 6
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Career Start Year 1972
Number of shared co-authors 7
Broad Institute of MIT and Harvard
Career Start Year 1966
Number of shared co-authors 0

Collaborators

University Hospital Zurich
Co-authored papers 38
University Hospital Zurich
Co-authored papers 16
Institute of Anatomy, University of Zurich
Co-authored papers 6
Institute of Anatomy, University of Zurich
Co-authored papers 5
Co-authored papers 5
University Hospital of Zurich
Co-authored papers 4
University Hospital Zurich
Co-authored papers 4
Zurich University Hospital
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
Institute of Anatomy, University of Zurich
Co-authored papers 2
Co-authored papers 2
University Hospital Zurich, University of Zurich
Co-authored papers 2
Netherlands Cancer Institute
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Co-authored papers 2
Institut fur Biochemie, Friedrich-Alexander-Universitat Erlangen-Nurnberg
Co-authored papers 2
University Hospital Zurich and University of Zurich
Co-authored papers 1
Northwestern University
Co-authored papers 1
David Geffen School of Medicine at University of California at Los Angeles
Co-authored papers 1
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Moores Cancer Center, University of California
Co-authored papers 1
Institute of Molecular and Clinical Ophthalmology Basel
Co-authored papers 1
Co-authored papers 1
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Universitatsspital Basel
Co-authored papers 1
University of Zurich
Co-authored papers 1
Co-authored papers 1